PipFarm $100,000 Account Review: Price, Rules & Verdict

Account Rules & Specs

Cost Breakdown

When you pay $750 for PipFarm's $100,000 account, you're getting access to one of the more restrictive prop firm challenges in the market. At 0.75% of the funded amount, the price appears reasonable compared to competitors like FTMO ($540) and FundedNext ($549.99), but the devil is in the details of what you're actually buying. The most significant limitation you'll face is the 2% daily loss limit per trade, enforced through their "Pip Protector" system. This isn't a traditional daily drawdown rule – it's a per-trade limit that severely restricts your position sizing. On a $100,000 account, you're limited to risking $2,000 per trade, which translates to roughly 0.4 standard lots on EUR/USD with a 50-pip stop loss. This makes it nearly impossible to use standard risk management approaches that many profitable traders rely on. The 6% total loss limit is calculated as an equity trailing loss from your high watermark, meaning once you start making profits, your maximum loss threshold moves up with your gains. While this protects your progress, it also creates pressure to maintain consistency throughout the challenge period. PipFarm's consistency rule requires your best trading day to represent no more than 25% of your total profit when in "Consistency Mode." This means if you make $1,000 total profit during the challenge, your highest single-day gain cannot exceed $250. For traders who occasionally hit big winners, this rule can be particularly challenging to navigate. The challenge structure appears to be single-phase, though the profit target for Phase 1 isn't clearly specified in their documentation. With no minimum trading days required and a 90-day time limit, you have flexibility in timing, but the restrictive daily rules mean you'll need to be active and consistent rather than relying on a few strong trading sessions. One genuine advantage is the 99% profit split – among the highest in the industry. Once funded, you keep 99% of your profits with payouts available every 7 days. This beats the standard 80% offered by FTMO and FundedNext, though you need to actually reach profitability first. The platform limitation to cTrader only may suit some traders, but the bigger issue is instrument availability. PipFarm restricts trading to forex only – no indices, commodities, crypto, or stocks. This significantly limits your trading opportunities compared to firms offering diverse asset classes. With 1:50 leverage on forex pairs, you have reasonable buying power, but it's constrained by the daily loss limits. Policy restrictions further limit your options. Weekend holding isn't allowed, EAs and copy trading are prohibited, and hedging strategies are banned. News trading policies aren't clearly defined, creating uncertainty around high-impact economic events. For scaling potential, PipFarm offers growth up to $1,500,000, which provides a reasonable progression path if you can navigate their restrictive rules consistently. Compared to alternatives, FTMO charges $540 for similar capital with a 10% profit target, 5% daily loss limit, and 80% profit split. While FTMO's target is higher, the 5% daily loss limit gives you significantly more flexibility in position sizing. FundedNext at $549.99 offers 8% profit target, 5% daily loss, and allows news trading with 80% profit split. The core question is whether the higher profit split justifies the restrictive trading environment. For most traders, the answer is likely no. The 2% daily loss limit is so restrictive that it fundamentally changes how you must approach trading, often forcing suboptimal position sizes that reduce profit potential. If you're considering PipFarm's $100,000 account, ensure you can trade profitably with very small position sizes and maintain perfect daily consistency. The firm appears legitimate with a 4.3/5 Trustpilot rating from 1,000 reviews, but their rules favor a very specific trading style that doesn't suit most profitable forex traders.

Alternatives to Consider

Frequently Asked Questions

Related